The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
Vester GunsaruMarc Yves Romain HenrionChristopher Finn McQuaidPublished in: BMC medicine (2024)
While for some countries and regions there were significant differences between observed and predicted treatment outcomes probabilities, there was insufficient evidence globally to identify systematic differences between observed and expected TB treatment outcome probabilities because of COVID-19-associated disruptions in general. However, larger numbers of treatment failures and deaths on treatment than expected were observed globally, suggesting a need for further investigation.